References
- De Souza LH, Bates D. Multiple sclerosis. In: Stokes M, Stack E, eds. Physical management in neurological rehabilitation. 3rd ed. London: Churchill Livingstone, Elsevier; 2012:85–115
- Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. New Eng J Med 2000;343:938–52
- Scalfari A, Neuhaus A, Degenhardt A, et al. The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability. Brain 2010;133:1914–29
- Kurtzke JF. A new scale for evaluating disability in multiple sclerosis. Neurology 1955;5:580–3
- Finlayson M, Guglielmello L, Liefer K. Describing and predicting the possession of assistive devices among persons with multiple sclerosis. Am J Occup Ther 2001;55:545–52
- Frank AO, Ward JH, Orwell NJ, et al. Introduction of the new NHS Electric Powered Indoor/outdoor Chair (EPIOC) service: benefits, risks and implications for prescribers. Clin Rehabil 2000;14:665–73
- Curtis KA, Roach KE, Applegate EB, et al. Reliability and validity of the Wheelchair User’s Shoulder Pain Index (WUSPI). Paraplegia 1995;33:595–601
- Fay BT, Boninger ML, Fitzgerald SG, et al. Manual wheelchair pushrim dynamics in people with multiple sclerosis. Arch Phys Med Rehabil 2004;85:935–42
- Souza A, Kelleher A, Cooper R, et al. Multiple sclerosis and mobility-related assistive technology: systematic review of literature. J Rehabil Res Dev 2010;47:213–23
- Horton M, Rudick RA, Hara-Cleaver C, Marrie RA. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiol 2010;35:83–90
- Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Euro J Neurol 2010;17:1215–19
- Marrie RA, Horwitz RI, Cutter G, et al. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand 2011;124:135–41
- Wojtowicz M, Cuthbertson A, Fisk JD, et al. Co-morbid medical conditions affect health-related quality of life in multiple sclerosis patients. Mult Scler 2011;17:S81–2
- Alschuler K, Ehde D, Jensen M. Understanding the co-occurrence of pain and depression in adults with multiple sclerosis. J Pain 2013;14:S20
- Bazelier MT, Van T, Uitdehaag BM, et al. The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Mineral Res 2011;26:2271–9
- Murray TJ. Pain management in patients with multiple sclerosis. Pain Res Manage 2000;5:77–80
- Frank AO, De Souza LH, Frank JL, Neophytou C. The pain experiences of powered wheelchair users. Disabil Rehabil 2012;34:770–8
- Arpaia G, Bavera PM, Caputo D, et al. Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study. Thrombosis Res 2010;125:315–17
- Evans S, Neophytou C, De Souza LH, Frank AO. Young people’s experiences using electric powered indoor-outdoor wheelchairs (EPIOCs): potential for enhancing users’ development? Disabil Rehabil 2007;19:1281–94
- Giesbrecht EM, Ripat JD, Quanbury AO, Cooper JE. Participation in community-based activities of daily living: comparison of a pushrim-activated, power-assisted wheelchair and a power wheelchair. Disabil Rehabil Assist Technol 2009;4:198–207
- Frank AO, Neophytou C, Frank J, De Souza LH. Electric powered indoor/outdoor wheelchairs (EPIOCs): users views of influence on family, friends and carers. Disabil Rehabil Assist Technol 2010;5:327–38
- Brandt A, Iwarsson S, Stahle A. Older people’s use of powered wheelchairs for activity and participation. J Rehabil Med 2004;36:70–7
- May M, Rugg S. Electrically powered indoor/outdoor wheelchairs: recipients views of their effects on occupational performance and quality of life. Br J Occup Ther 2010;73:2–12
- Davies A, De Souza LH, Frank AO. Changes in the quality of life in severely disabled people following provision of powered indoor/outdoor chairs. Disabil Rehabil 2003;25:286–90
- Department of Health. Powered indoor/outdoor wheelchairs for severely disabled people. NHS executive Health Service Guidelines HSG (96)34 [May 1996], 1–10. London: Department of Health; 1996
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52
- Matthews B. Symptoms and signs of multiple sclerosis. In: Compston A, Ebers G, Lassman H, et al., eds. McAlpine’s multiple sclerosis. 3rd ed. London: Churchill Livingstone; 1998:145–90
- British Society of Rehabilitation Medicine. Specialised wheelchair seating national clinical guidelines. Report of a multidisciplinary expert group (Chair: Marks, LJ). London: British Society of Rehabilitation Medicine; 2004:1–39
- Dewey A, Rice-Oxley M, Dean T. A qualitative study comparing the experiences of tilt-in-space wheelchair use and conventional wheelchair use by clients severely disabled with multiple sclerosis. Br J Occup Ther 2004;67:65–74
- Devitt R, Chau B, Jutai J. The effect of wheelchair use on the quality of life of persons with multiple sclerosis. Occup Ther Health Care 2004;17:63–79
- Chan A, Heck CS. The effects of tilting the seating position of a wheelchair on respiration, posture, fatigue, voice volume, and exertion outcomes in individuals with advanced multiple sclerosis. J Rehabil Outcomes Measure 1999;3:1–14
- Riudavets MA, Colegial C, Rubio A, et al. Causes of unexpected death in patients with multiple sclerosis: a forensic study of 50 cases. Am J Forensic Med Pathol 2005;26:244–9
- Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to the multimorbidity challenge. Brit Med J 2012;345:11–12
- National Institute for Clinical Excellence. Multiple sclerosis - national clinical guidelines for NHS Management in Primary and Secondary Care. London: National Institute for Clinical Excellence; 2005
- Formica CA, Cosman F, Nieves J, et al. Reduced bone mass and fat free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcified Tissue Internat 1997;61:129–33
- Christiansen CF. Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res 2012;34:746–53
- Crane DA, Little JW, Burns SP. Weight gain following spinal cord injury: a pilot study. J Spinal Cord Med 2011;34:227–32
- Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 2010;9:820–8
- Khurana SR, Bamer AM, Turner AP, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil 2009;88:83–91
- Bauer SM, Elsaesser LJ, Arthanat S. Assistive technology device classification based upon the World Health Organization’s, International Classification of Functioning. Disabil Rehabil Assist Technol 2011;6:243–59
- Omachi TA, Gregorich SE, Eisner MD, et al. Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity? Medical Care 2013;51:740–7
- Rosso C, Remy P, Creange A, et al. Diffusion-weighted MR imaging characteristics of an acute stroke-like form of multiple sclerosis. Am J Neuroradiol 2006;27:1006–8
- Fay BT, Boninger ML. The science behind mobility devices for individuals with multiple sclerosis. Med Eng Physics 2002;24:375–83
- Frank AO, De Souza LH. Recipients of electric powered indoor/outdoor wheelchairs (EPIOCs) provided by a National Health Service: a cross sectional study. Arch Phys Med Rehabil 2013;94:2403–9